GLP-1 prices are dropping: Who exactly will benefit?

Group 1 - The core focus is on the accessibility and pricing of GLP-1 medications for patients under commercial insurance plans and pharmacy benefit managers (PBMs) [2][3] - Companies are committed to ensuring that the prices for GLP-1s are at least at the Most Favored Nation (MFN) level and will negotiate prices down based on volume [2] - There is a trend where commercial plans and PBMs are allowing beneficiaries to purchase medications in the cash market while still receiving coverage under their deductibles and accumulators [3]